Evolving Nephrotropic AAV Variants Using Ex Vivo NHP Kidney Perfusion and Human Kidney Organoids
Publication
, Conference
Rosales, A; Blondel, LO; Gao, Q; Barbas, AS; Asokan, A
Published in: MOLECULAR THERAPY
2023
Duke Scholars
Published In
MOLECULAR THERAPY
EISSN
1525-0024
ISSN
1525-0016
Publication Date
2023
Volume
31
Issue
4
Start / End Page
180 / 180
Related Subject Headings
- Biotechnology
- 3206 Medical biotechnology
- 3202 Clinical sciences
- 3105 Genetics
- 11 Medical and Health Sciences
- 10 Technology
- 06 Biological Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Rosales, A., Blondel, L. O., Gao, Q., Barbas, A. S., & Asokan, A. (2023). Evolving Nephrotropic AAV Variants Using Ex Vivo NHP Kidney Perfusion and Human Kidney Organoids. In MOLECULAR THERAPY (Vol. 31, pp. 180–180).
Rosales, Alan, Leo O. Blondel, Qimeng Gao, Andrew S. Barbas, and Aravind Asokan. “Evolving Nephrotropic AAV Variants Using Ex Vivo NHP Kidney Perfusion and Human Kidney Organoids.” In MOLECULAR THERAPY, 31:180–180, 2023.
Rosales A, Blondel LO, Gao Q, Barbas AS, Asokan A. Evolving Nephrotropic AAV Variants Using Ex Vivo NHP Kidney Perfusion and Human Kidney Organoids. In: MOLECULAR THERAPY. 2023. p. 180–180.
Rosales, Alan, et al. “Evolving Nephrotropic AAV Variants Using Ex Vivo NHP Kidney Perfusion and Human Kidney Organoids.” MOLECULAR THERAPY, vol. 31, no. 4, 2023, pp. 180–180.
Rosales A, Blondel LO, Gao Q, Barbas AS, Asokan A. Evolving Nephrotropic AAV Variants Using Ex Vivo NHP Kidney Perfusion and Human Kidney Organoids. MOLECULAR THERAPY. 2023. p. 180–180.
Published In
MOLECULAR THERAPY
EISSN
1525-0024
ISSN
1525-0016
Publication Date
2023
Volume
31
Issue
4
Start / End Page
180 / 180
Related Subject Headings
- Biotechnology
- 3206 Medical biotechnology
- 3202 Clinical sciences
- 3105 Genetics
- 11 Medical and Health Sciences
- 10 Technology
- 06 Biological Sciences